Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | 69,302 | reported | 09 Mar 2026 | tx 30+1,636,437−1,350,308 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 104,467 | — | |
| 05 Mar 2026 | SALE | NewAmsterdam Pharma Co N.V. | 104,467 | 30.30 USD | |
| 06 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 94,124 | — | |
| 06 Mar 2026 | SALE | NewAmsterdam Pharma Co N.V. | 94,124 | 30.32 USD | |
| 09 Mar 2026 | SALE | NewAmsterdam Pharma Co N.V. | 101,409 | 30.29 USD | |
| 09 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 101,409 | — | |
| 09 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 101,409 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 94,124 | 0.00 USD | deriv |
| 05 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 104,467 | 0.00 USD | deriv |
| 20 Feb 2026 | SALE | NewAmsterdam Pharma Co N.V. | 30,789 | 35.46 USD | |
| 20 Feb 2026 | SALE | NewAmsterdam Pharma Co N.V. | 14,692 | 35.00 USD | |
| 05 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 6,000 | 33.25 USD | |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 25,500 | — | |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 115,000 | 0.00 USD | deriv |
| 21 Aug 2025 | SALE | NewAmsterdam Pharma Co N.V. | 50,000 | 24.29 USD | |
| 22 Aug 2025 | SALE | NewAmsterdam Pharma Co N.V. | 7,658 | 25.49 USD | |
| 22 Aug 2025 | SALE | NewAmsterdam Pharma Co N.V. | 42,342 | 25.08 USD | |
| 26 Mar 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 45,481 | 0.00 USD | |
| 26 Mar 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 19,302 | 0.00 USD | |
| 26 Mar 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 45,481 | — | deriv |
| 26 Mar 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 45,481 | — | deriv |
| 24 Mar 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 150,000 | — | |
| 24 Mar 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 150,000 | 0.00 USD | deriv |
| 07 Jan 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 34,000 | — | |
| 02 Jan 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 200,000 | 0.00 USD | deriv |